Explore more publications!

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on December 4, 2025

ED&VINI LLC Introduces Art Series Linking Tessellation Art to American Cultural Symbols
Choroideremia Research Foundation Announces Grant Application Deadline: December 31, 2025
'Exploring God's World: Pictures and Bible Verses' by Jean Robinson is a Journey Through Creation, Faith, and Hope
CFOs of Wayfair, Hasbro, and Sysdig to Headline Spring 2026 CFO Leadership Conference in Boston
Electra Vehicles Returns to CES 2026 to Showcase the Future of Battery Intelligence
LiveData Appoints Jeffrey H. Forbes as VP of Commercial Healthcare Sales to Drive Strategic Growth and Partnerships
Postalytics Launches Canva Integration to Transform Direct Mail Production
Forward Is a Pace Indoor Timed Triathlon, Led by Race Director Adina O’Neill, Continues to Grow in Popularity
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
HAProxy Confirmed as the Unshakeable Standard for Enterprise Load Balancing in G2 Winter 2026 Reports
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
pdfFiller Launches AI PDF Summarizer to Accelerate Document Review
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
Parexel Showcases Industry-Leading Hematology Expertise with Presentation of 10 Research Posters at the American Society of Hematology (ASH) Annual Meeting
Alkeus Pharmaceuticals Announces Gildeuretinol Data Will Be Presented During the 13th International FLORetina ICOOR Congress December 4–7 in Florence, Italy
Diagonal Therapeutics to Present Insights from HHT IMPACT, a Natural History Study Initiated in Partnership with Cure HHT, at ASH 2025
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
Vertero Appoints Jeffrey Kasten as Chief Business Officer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions